Many Drugs Made Available Via FDA Expanded Access Programs
Half of meds ID'd in expanded access programs treat cancer; others for metabolic, endocrine diseases
HbA1c Targets Should Be Personalized in Type 2 Diabetes
Target HbA1c 7% to 8% for most patients with T2DM; deintensification of tx with HbA1c <6.5%
Attitudes Among Obese Are Not Aligned With Healthy Living
Consumers with obesity report favoring taste and value rather than health and nutrition
Adult Obesity Prevalence Varies With Level of Urbanization
Increased obesity for men, women living in medium, small versus large metropolitan statistical areas
Recent-Onset Diabetes Tied to Increased Pancreatic Cancer Risk
Latinos, African-Americans with recent-onset disease have higher risk than those with long-term disease
Less Improvement in AHA Diet Score for SNAP Participants
Disparities persisted for most foods and nutrients; worsened for processed meats, added sugars
Considerable Costs Associated With Switching EHR
Costs include time needed for research and testing, maintenance and other fees, hardware updates
Prevalence of Obesity 17.8 Percent for Youth in 2013 to 2016
Prevalence of severe obesity significantly higher among U.S. youth in non-metropolitan statistical areas
Cleared Blood Glucose Monitor Systems Not Always Accurate
Six of 18 systems met predetermined accuracy standard in three of three studies
CDC: Obesity Prevalence Higher in Non-Metropolitan Counties
Largest absolute difference for non-metropolitan versus metropolitan counties in South, Northeast
